Document is current
Any future updates will be listed below
-
Authors
Meng, Meng
Liu, Fang
Ma, Yilong
Qin, Wen
Guo, Lining
Peng, Shichun
Gordon, Marc L.
Wang, Yue
Zhang, Nan https://orcid.org/0000-0002-9675-5322
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (81870831)
Tianjin Key Medical Discipline (Specialty) Construction Project (TJYXZDXK-004A)
- License Information
-
More Information
Article History
Received: 24 November 2021
Accepted: 28 March 2023
First Online: 10 April 2023
Declarations
:
: The Ethics Committee of Tianjin Medical University General Hospital approved this study. Written informed consent was obtained from all participants.
: Not applicable.
: Dr. Gordon has received research support without direct compensation from Eisai, AbbVie, Janssen, Novo Nordisk, and Alector and has been a consultant for METiS Pharmaceuticals. Dr. Ma has received research funding from AskBio Pharmaceuticals and Blue Rock Therapeutics. Other authors have no conflicts of interest to declare.
